Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Vaccine Helper Targets Muscle Cells

July 21, 2008 | A version of this story appeared in Volume 86, Issue 29

Vaccines are formulated with additives that enhance their immune-stimulating effects. Although these "adjuvants" have been used for many years, their mechanism of action and cellular targets remain unknown. Ennio De Gregorio, Rino Rappuoli, and coworkers at Novartis Vaccines & Diagnostics, in Siena, Italy, have used DNA microarray analysis to identify the genes affected by three types of adjuvants (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.0804699105). Following injections in mouse muscle, the oil-in-water emulsion MF59, a common adjuvant in flu vaccines, induced changes in the expression of 891 genes, whereas CpG and alum, two other common adjuvants, affected only 387 and 312 genes, respectively. Some genes were modulated only when MF59 and CpG were administered together. The researchers identified 168 "adjuvant core-response genes" affected by all three adjuvants. These core genes regulate the expression of molecules that are usually associated with inflammatory responses. MF59 induced stronger and faster immune responses than CpG or alum. The researchers discovered two biomarkers that they used to identify muscle cells as the primary target of MF59.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.